SCHEMBL2707489

SCHEMBL2707489

CC(=O)Oc1ccc(Oc2ccc(C(=O)O)cc2)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.55
KDM4E B2RXH2 2/20 0.55
ALDH1A1 P00352 2/20 0.55
RAB9A P51151 2/20 0.55
GAA P10253 1/20 0.55
KMO O15229 1/20 0.52
HSD17B10 Q99714 1/20 0.51
SRD5A2 P31213 2/20 0.49
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
RXRG P48443 1/20 0.47
PARP15 Q460N3 1/20 0.46
PARP10 Q53GL7 1/20 0.46
MRGPRX4 Q96LA9 2/20 0.46
PKM P14618 1/20 0.45
TTR P02766 2/20 0.45
CCR1 P32246 1/20 0.44
CCR2 P41597 1/20 0.44
CCR5 P51681 1/20 0.44
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2706323 0.88 TSHR (0.51) TSHRKDM4EALDH1A1RAB9AGAA
SCHEMBL6047542 0.84 TSHR (0.71) TSHRKDM4EALDH1A1RAB9AGAA
SCHEMBL17791828 0.83 BACE1 (0.47) TSHRKMOPKMHPGD
Hydrochloric Acid SCHEMBL9735406 0.83 TSHR (0.69) TSHRKDM4EALDH1A1RAB9AGAA
SCHEMBL2716095 0.82 KMO (0.73) TSHRKMOSRD5A2RXRARXRB
SCHEMBL29752779 0.82 KMO (0.73) TSHRKMOSRD5A2RXRARXRB
SCHEMBL12996678 0.81 PARP10 (0.45) KDM4EALDH1A1GAAKMOPARP10
SCHEMBL7161621 0.81 KDM4E (0.56) TSHRKDM4EALDH1A1RAB9AGAA
SCHEMBL10455915 0.79 HSD17B10 (0.79) TSHRKDM4EALDH1A1RAB9AGAA
SCHEMBL6310027 0.79 HSD17B10 (0.79) TSHRKDM4EALDH1A1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102448978-A Novel Glucocorticoid Receptor Agonists PFIZER LTD 2012-05-09 CN disclosed
EP-2435462-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS Pfizer Limited (GB) 2012-04-04 EP disclosed
WO-2010136940-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS PFIZER LIMITED (GB) 2010-12-02 WO disclosed
WO-2010136940-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS PFIZER LIMITED (GB) 2010-12-02 WO disclosed
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists GLOSSOP PAUL ALAN 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists NR3C1, NR3C2, MC2R TSHR 431/4885KDM4E 3887/4885ALDH1A1 2013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.